Liver Cancer Diagnostics Market Size, Share & Trends Report

Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-3-68038-012-5
Number of Pages: 180
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Liver Cancer Diagnostics Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Laboratory Tests
  - Biomarkers
    - Oncofetal and Glycoprotein Antigens
    - Enzymes and Isoenzymes
    - Growth Factors and Receptors
    - Molecular Markers
    - Pathological Biomarkers
  - Blood Tests
- Imaging
- Endoscopy
- Biopsy
- Others
Liver Cancer Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
Liver Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Liver Cancer Diagnostics Market, By Test Type
    - Laboratory Tests
      - Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
      - Blood Tests
    - Imaging
    - Endoscopy
    - Biopsy
    - Others
  - North America Liver Cancer Diagnostics Market, By End-use
    - Hospitals & Diagnostic Laboratories
    - Academic & Research Institutes
    - Pharmaceutical & CRO Laboratories
  - U.S.
    - U.S. Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - U.S. Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Canada
    - Canada Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Canada Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Rest of North America
    - Rest of North America Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Rest of North America Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
- Europe
  - Europe Liver Cancer Diagnostics Market, By Test Type
    - Laboratory Tests
      - Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
      - Blood Tests
    - Imaging
    - Endoscopy
    - Biopsy
    - Others
  - Europe Liver Cancer Diagnostics Market, By End-use
    - Hospitals & Diagnostic Laboratories
    - Academic & Research Institutes
    - Pharmaceutical & CRO Laboratories
  - U.K.
    - U.K. Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - U.K. Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Germany
    - Germany Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Germany Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - France
    - France Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - France Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Italy
    - Italy Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Italy Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Spain
    - Spain Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Spain Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Denmark
    - Denmark Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Denmark Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Sweden
    - Sweden Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Sweden Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Norway
    - Norway Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Norway Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Rest of Europe
    - Rest of Europe Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Rest of Europe Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
- Asia Pacific
  - Asia Pacific Liver Cancer Diagnostics Market, By Test Type
    - Laboratory Tests
      - Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
      - Blood Tests
    - Imaging
    - Endoscopy
    - Biopsy
    - Others
  - Asia Pacific Liver Cancer Diagnostics Market, By End-use
    - Hospitals & Diagnostic Laboratories
    - Academic & Research Institutes
    - Pharmaceutical & CRO Laboratories
  - Japan
    - Japan Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Japan Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - China
    - China Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - China Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - India
    - India Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - India Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - South Korea
    - South Korea Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - South Korea Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Australia
    - Australia Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Australia Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Thailand
    - Thailand Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Thailand Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Rest of Asia Pacific
    - Rest of Asia Pacific Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Rest of Asia Pacific Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
- Latin America
  - Latin America Liver Cancer Diagnostics Market, By Test Type
    - Laboratory Tests
      - Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
      - Blood Tests
    - Imaging
    - Endoscopy
    - Biopsy
    - Others
  - Latin America Liver Cancer Diagnostics Market, By End-use
    - Hospitals & Diagnostic Laboratories
    - Academic & Research Institutes
    - Pharmaceutical & CRO Laboratories
  - Brazil
    - Brazil Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Brazil Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Mexico
    - Mexico Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Mexico Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Argentina
    - Argentina Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Argentina Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Rest of Latin America
    - Rest of Latin America Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Rest of Latin America Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
- Middle East & Africa (MEA)
  - MEA Liver Cancer Diagnostics Market, By Test Type
    - Laboratory Tests
      - Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
      - Blood Tests
    - Imaging
    - Endoscopy
    - Biopsy
    - Others
  - MEA Liver Cancer Diagnostics Market, By End-use
    - Hospitals & Diagnostic Laboratories
    - Academic & Research Institutes
    - Pharmaceutical & CRO Laboratories
  - South Africa
    - South Africa Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - South Africa Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Saudi Arabia
    - Saudi Arabia Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Saudi Arabia Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - UAE
    - UAE Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - UAE Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Kuwait
    - Kuwait Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Kuwait Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories
  - Rest of Middle East & Africa
    - Rest of Middle East & Africa Liver Cancer Diagnostics Market, By Test Type
      - Laboratory Tests
        
        Biomarkers
        
        Oncofetal and Glycoprotein Antigens
        
        Enzymes and Isoenzymes
        
        Growth Factors and Receptors
        
        Molecular Markers
        
        Pathological Biomarkers
        
        Blood Tests
      - Imaging
      - Endoscopy
      - Biopsy
      - Others
    - Rest of Middle East & Africa Liver Cancer Diagnostics Market, By End-use
      - Hospitals & Diagnostic Laboratories
      - Academic & Research Institutes
      - Pharmaceutical & CRO Laboratories

Liver Cancer Diagnostics Market Dynamics

Driver: Increasing prevalence of risk factors for liver cancer

Hepatitis A, B, and C are the most commonly occurring variants of the hepatitis virus. According to WHO, over 71 million individuals are currently suffering from chronic hepatitis C, with over 399,000 related deaths. Hepatitis B virus is a bloodborne pathogen associated with complications such as HCC and liver cirrhosis. In Africa and Southeast Asian countries, where the endemic is high and resources are limited, delays in diagnosis are a major causative factor for liver cancer & other liver diseases. The incidence of viral hepatitis in developed economies is relatively lower than developing ones, owing to the availability of modern technologies in disease diagnosis, therapies, and preventive measures. Various expanded programs for immunization against the Hepatitis B virus have also been a significant reason for the lower incidence in these regions. China carries the largest burden of liver diseases; it is estimated that over one-fifth of the country’s population is affected by some form of liver disease, typically HBV or HCV infections, liver cirrhosis, Non-alcoholic Fatty Liver Disease (NAFLD), liver cancer, and Alcohol-related Liver Disease (ALD).

An increase in initiatives undertaken by private and government organizations is anticipated to improve awareness and prompt more individuals to undergo early screening. The Korean Liver Foundation has undertaken an initiative wherein the Korea Disease Control and Prevention Agency (KDCA) has been conducting pilot Hepatitis C testing, free of cost. It is estimated that almost 50% of Hepatitis C patients also suffer from fatty liver disease. Thus, an increase in initiatives is anticipated to further boost awareness about the benefits of early disease screening.

Restraint: High cost of diagnostic imaging

Diagnostic tests of cancer are expensive, increasing the financial burden on families of patients. Government-based insurance frameworks are typically not well-defined in developing economies, as they are in developed ones. Thus, the middle-income patient population, which is generally not covered under any insurance scheme (private or government), cannot afford these tests. In addition, many private insurance players do not cover costs associated with cancer diagnosis in developing economies. As a result, the high cost of diagnosis is limiting the adoption of cancer screening tools in such regions. However, the scenario is expected to change over the coming years in certain countries, owing to the booming medical tourism industry. These countries include India and Malaysia, wherein healthcare treatments & diagnostic solutions are becoming increasingly affordable as a secondary benefit of growing medical tourism.

Opportunity: Advent of personalized medicine and companion diagnostics

Personalized medicine promises a paradigm shift in diagnosis and care delivery as the treatment planning is based on data obtained through a holistic approach. Proliferation of sequencing methodologies, especially Next-Generation Sequencing (NGS), due to increased cost of sequencing and development of the Human Genome Project, is expected to drive the market. NGS technology delivers data related to the genetic makeup of patients and their response to drugs, thereby promoting development of precision medicine to effectively treat diseases. Major companies operating in the personalized medicine market are involved in several investment programs pertaining to precision medicine. Furthermore, companies providing molecular decision support systems are combining genomic data with clinical data to minimize the gaps in precision medicine practice. One of the biggest advancements in the field of personalized medicine for blood cancer is the advent of Gleevec for the treatment of Chronic Myelogenous Leukemia (CML). Similarly, targeted therapy has proven to be highly successful in treating breast, colorectal, and lung cancers, as well as melanoma, significantly improving mortality rates.

What Does This Report Include?

This section will provide insights into the contents included in this liver cancer diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Liver cancer diagnostics market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Liver cancer diagnostics market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.